Search PDMR transactions

Notifier
Name of person with notification obligation
Andreas Gerward
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Andreas Gerward
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Stayble Therapeutics AB
Issuer´s LEI code
549300WD23DE1US21868
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Stayble Therapeutics AB SE0013513652 Acquisition 15,000 Quantity 4.89 SEK 31/08/2022 FIRST NORTH SWEDEN
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Stayble Therapeutics AB SE0013513652 Acquisition 31/08/2022 FIRST NORTH SWEDEN 15,000 (Quantity) 4.89 SEK
<< Back